Clinical Trial Update: Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

View source ↗

Summary

A completed clinical trial evaluating whole-body MRI, circulating DNA, and PET-CT for staging, prognosis, and treatment response in patients with diffuse large …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Lymphoma, Diffuse Large B-Cell | Status: COMPLETED